2025-01-012025-12-312025-12-31false06577021EMBECOSM LIMITED2026-09-18falseiso4217:GBPxbrli:pure065770212024-12-31065770212025-12-31065770212025-01-012025-12-31065770212023-12-31065770212024-12-31065770212024-01-012024-12-3106577021bus:SmallEntities2025-01-012025-12-3106577021bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3106577021bus:FullAccounts2025-01-012025-12-3106577021bus:PrivateLimitedCompanyLtd2025-01-012025-12-3106577021core:WithinOneYear2025-12-3106577021core:AfterOneYear2025-12-3106577021core:WithinOneYear2024-12-3106577021core:AfterOneYear2024-12-3106577021core:ShareCapital2025-12-3106577021core:SharePremium2025-12-3106577021core:RevaluationReserve2025-12-3106577021core:OtherReservesSubtotal2025-12-3106577021core:RetainedEarningsAccumulatedLosses2025-12-3106577021core:ShareCapital2024-12-3106577021core:SharePremium2024-12-3106577021core:RevaluationReserve2024-12-3106577021core:OtherReservesSubtotal2024-12-3106577021core:RetainedEarningsAccumulatedLosses2024-12-3106577021core:LandBuildings2025-12-3106577021core:PlantMachinery2025-12-3106577021core:Vehicles2025-12-3106577021core:FurnitureFittings2025-12-3106577021core:OfficeEquipment2025-12-3106577021core:NetGoodwill2025-12-3106577021core:IntangibleAssetsOtherThanGoodwill2025-12-3106577021core:ListedExchangeTraded2025-12-3106577021core:UnlistedNon-exchangeTraded2025-12-3106577021core:LandBuildings2024-12-3106577021core:PlantMachinery2024-12-3106577021core:Vehicles2024-12-3106577021core:FurnitureFittings2024-12-3106577021core:OfficeEquipment2024-12-3106577021core:NetGoodwill2024-12-3106577021core:IntangibleAssetsOtherThanGoodwill2024-12-3106577021core:ListedExchangeTraded2024-12-3106577021core:UnlistedNon-exchangeTraded2024-12-3106577021core:LandBuildings2025-01-012025-12-3106577021core:PlantMachinery2025-01-012025-12-3106577021core:Vehicles2025-01-012025-12-3106577021core:FurnitureFittings2025-01-012025-12-3106577021core:OfficeEquipment2025-01-012025-12-3106577021core:NetGoodwill2025-01-012025-12-3106577021core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3106577021core:ListedExchangeTraded2025-01-012025-12-3106577021core:UnlistedNon-exchangeTraded2025-01-012025-12-3106577021core:MoreThanFiveYears2025-01-012025-12-3106577021core:Non-currentFinancialInstruments2025-12-3106577021core:Non-currentFinancialInstruments2024-12-3106577021dpl:CostSales2025-01-012025-12-3106577021dpl:DistributionCosts2025-01-012025-12-3106577021core:LandBuildings2025-01-012025-12-3106577021core:PlantMachinery2025-01-012025-12-3106577021core:Vehicles2025-01-012025-12-3106577021core:FurnitureFittings2025-01-012025-12-3106577021core:OfficeEquipment2025-01-012025-12-3106577021dpl:AdministrativeExpenses2025-01-012025-12-3106577021core:NetGoodwill2025-01-012025-12-3106577021core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3106577021dpl:GroupUndertakings2025-01-012025-12-3106577021dpl:ParticipatingInterests2025-01-012025-12-3106577021dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3106577021core:ListedExchangeTraded2025-01-012025-12-3106577021dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3106577021core:UnlistedNon-exchangeTraded2025-01-012025-12-3106577021dpl:CostSales2024-01-012024-12-3106577021dpl:DistributionCosts2024-01-012024-12-3106577021core:LandBuildings2024-01-012024-12-3106577021core:PlantMachinery2024-01-012024-12-3106577021core:Vehicles2024-01-012024-12-3106577021core:FurnitureFittings2024-01-012024-12-3106577021core:OfficeEquipment2024-01-012024-12-3106577021dpl:AdministrativeExpenses2024-01-012024-12-3106577021core:NetGoodwill2024-01-012024-12-3106577021core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3106577021dpl:GroupUndertakings2024-01-012024-12-3106577021dpl:ParticipatingInterests2024-01-012024-12-3106577021dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3106577021core:ListedExchangeTraded2024-01-012024-12-3106577021dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3106577021core:UnlistedNon-exchangeTraded2024-01-012024-12-3106577021core:NetGoodwill2025-12-3106577021core:IntangibleAssetsOtherThanGoodwill2025-12-3106577021core:LandBuildings2025-12-3106577021core:PlantMachinery2025-12-3106577021core:Vehicles2025-12-3106577021core:FurnitureFittings2025-12-3106577021core:OfficeEquipment2025-12-3106577021core:AfterOneYear2025-12-3106577021core:WithinOneYear2025-12-3106577021core:ListedExchangeTraded2025-12-3106577021core:UnlistedNon-exchangeTraded2025-12-3106577021core:ShareCapital2025-12-3106577021core:SharePremium2025-12-3106577021core:RevaluationReserve2025-12-3106577021core:OtherReservesSubtotal2025-12-3106577021core:RetainedEarningsAccumulatedLosses2025-12-3106577021core:NetGoodwill2024-12-3106577021core:IntangibleAssetsOtherThanGoodwill2024-12-3106577021core:LandBuildings2024-12-3106577021core:PlantMachinery2024-12-3106577021core:Vehicles2024-12-3106577021core:FurnitureFittings2024-12-3106577021core:OfficeEquipment2024-12-3106577021core:AfterOneYear2024-12-3106577021core:WithinOneYear2024-12-3106577021core:ListedExchangeTraded2024-12-3106577021core:UnlistedNon-exchangeTraded2024-12-3106577021core:ShareCapital2024-12-3106577021core:SharePremium2024-12-3106577021core:RevaluationReserve2024-12-3106577021core:OtherReservesSubtotal2024-12-3106577021core:RetainedEarningsAccumulatedLosses2024-12-3106577021core:NetGoodwill2023-12-3106577021core:IntangibleAssetsOtherThanGoodwill2023-12-3106577021core:LandBuildings2023-12-3106577021core:PlantMachinery2023-12-3106577021core:Vehicles2023-12-3106577021core:FurnitureFittings2023-12-3106577021core:OfficeEquipment2023-12-3106577021core:AfterOneYear2023-12-3106577021core:WithinOneYear2023-12-3106577021core:ListedExchangeTraded2023-12-3106577021core:UnlistedNon-exchangeTraded2023-12-3106577021core:ShareCapital2023-12-3106577021core:SharePremium2023-12-3106577021core:RevaluationReserve2023-12-3106577021core:OtherReservesSubtotal2023-12-3106577021core:RetainedEarningsAccumulatedLosses2023-12-3106577021core:AfterOneYear2025-01-012025-12-3106577021core:WithinOneYear2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3106577021core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3106577021core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3106577021core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3106577021core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3106577021core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3106577021bus:Director12025-01-012025-12-3106577021core:FurnitureFittingsToolsEquipment2024-12-3106577021core:FurnitureFittingsToolsEquipment2025-01-012025-12-3106577021core:FurnitureFittingsToolsEquipment2025-12-31

EMBECOSM LIMITED

Registered Number
06577021
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

EMBECOSM LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Director

BENNETT, Jeremy Peter, Dr

Company Secretary

BENNETT, Jennifer Clare

Registered Address

22 London Road
Southampton
SO15 2AF

Registered Number

06577021 (England and Wales)
EMBECOSM LIMITED
Statement of Financial Position
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets419,93124,183
Investments528,94528,945
48,87653,128
Current assets
Debtors6631,259613,866
Cash at bank and on hand351,104107,235
982,363721,101
Creditors amounts falling due within one year7(368,886)(172,992)
Net current assets (liabilities)613,477548,109
Total assets less current liabilities662,353601,237
Provisions for liabilities8(5,022)(6,046)
Net assets657,331595,191
Capital and reserves
Called up share capital1,5041,504
Profit and loss account655,827593,687
Shareholders' funds657,331595,191
The financial statements were approved and authorised for issue by the Director on 18 September 2026, and are signed on its behalf by:
BENNETT, Jeremy Peter, Dr
Director
Registered Company No. 06577021
EMBECOSM LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified.
Government grants or assistance
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
2.Average number of employees

20252024
Average number of employees during the year810
3.Deferred tax
Increases in the UK Corporation tax rate from 19% to 25% (19% effective from 1 April 2017, and 25% effective from 1 April 2023) have been substantively enacted. This will impact the company's future tax charge accordingly. The value of the deferred tax assets at the balance sheet date has been calculated using the applicable rate when the asset is expected to be realised. Deferred tax balance as at 31.12.25 £5,022 (2024 6,046)
4.Tangible fixed assets

Plant & machinery

Fixtures & fittings

Total

£££
Cost or valuation
At 01 January 2590,40323,732114,135
Additions2,9881,2534,241
At 31 December 2593,39124,985118,376
Depreciation and impairment
At 01 January 2581,0698,88389,952
Charge for year5,0513,4428,493
At 31 December 2586,12012,32598,445
Net book value
At 31 December 257,27112,66019,931
At 31 December 249,33414,84924,183
5.Fixed asset investments

Investments in groups1

Total

££
Cost or valuation
At 01 January 2528,94528,945
At 31 December 2528,94528,945
Net book value
At 31 December 2528,94528,945
At 31 December 2428,94528,945

Notes

1Investments in group undertakings and participating interests
6.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables222,928203,442
Amounts owed by group undertakings48,230228,728
Other debtors203,649127,024
Prepayments and accrued income156,45254,672
Total631,259613,866
Included within other debtors are intercompany payments due of £247,318 (2024 £352,761)
7.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables60,19711,610
Taxation and social security102,94019,473
Other creditors202,340127,527
Accrued liabilities and deferred income3,40914,382
Total368,886172,992
The Directors Loan was fully repaid during the year and is now Nil. (2024 £124,336). This was non interest bearing and repayable upon demand.
8.Provisions for liabilities
A bad debt provision of £199,089 has been provided for relating to an intercompany debt that is uncertain will be paid.

2025

2024

££
Net deferred tax liability (asset)5,0226,046
Total5,0226,046
9.Operating lease commitments
At 31 December 2025 the company had the following future minimum lease payments under non-cancellable operating leases for each of the following periods: 2025 2024 Not later than one year £25,000 £25,000 Later than one year and not later than five years £72,917 £97,917
10.Related party transactions
All related party transactions during the year were undertaken with the following subsidiaries, they were all at arms length and commercial in nature. Embecosm GMBH Embecosm SAS
11.Parent-subsidiary relationships
Embecosm Limited wholly owns the following subsidiaries: Embecosm GMBH (a company incorporated in Germany). Embecsom SAS (a company incorporated in France). The company has taken advantage of the option not to prepare consolidated financial statements contained in Section 398 of the Companies Act 2006 on the basis that the Company and its Subsidiaries comprise a small group.